Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

BACKGROUND: The hepatitis C virus (HCV) infects nearly 3% of the World's population, causing severe liver disease in many. Standard of care therapy is currently pegylated interferon alpha and ribavirin (PegIFN/R), which is effective in less than half of those infected with the most common viral...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Katherine R, Suppiah, Vijayaprakash, O'Connor, Kate, Berg, Thomas, Weltman, Martin, Abate, Maria Lorena, Spengler, Ulrich, Bassendine, Margaret, Matthews, Gail, Irving, William L, Powell, Elizabeth, Riordan, Stephen, Ahlenstiel, Golo, Stewart, Graeme J, Bahlo, Melanie, George, Jacob, Booth, David R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238183/
https://www.ncbi.nlm.nih.gov/pubmed/21884576
http://dx.doi.org/10.1186/gm273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238183/
https://www.ncbi.nlm.nih.gov/pubmed/21884576
http://dx.doi.org/10.1186/gm273

Ejemplares similares